Crescent Capital BDC, Inc. is a business development company. The company is headquartered in United States.
| Revenue (TTM) | $156.40M |
| Gross Profit (TTM) | $156.40M |
| EBITDA | — |
| Operating Margin | 78.40% |
| Return on Equity | -0.46% |
| Return on Assets | 4.59% |
| Revenue/Share (TTM) | $4.23 |
| Book Value | $17.82 |
| Price-to-Book | 0.54 |
| Price-to-Sales (TTM) | 2.25 |
| EV/Revenue | 179.42 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -14.90% |
| Quarterly Revenue Growth (YoY) | -15.50% |
| Shares Outstanding | $36.85M |
| Float | $27.98M |
| % Insiders | 3.40% |
| % Institutions | 71.54% |
Volatility is currently expanding
Crescent Capital is upgraded from ‘Buy' to ‘Strong Buy' due to improved dividend coverage and a compelling valuation. CCAP's 19% dividend cut enhanced coverage, with Q2 net investment income covering the dividend at 106%. Management lowered both management and incentive fees, further supporting future dividend stability and income profile.
Five high-yield tickers have ex-dividend dates arriving in days, and buying even one session too late means the seller collects your payment instead.
Six stocks are paying yields as high as 23% right now, but behind those numbers sit eroding asset values, razor-thin coverage ratios, and balance sheets that leave almost no room for error if rates or charter markets move the wrong
Crescent Capital BDC is rated HOLD, with the stock trading at a record 0.600x NAV and an attractive 12.7% yield. The dividend was reset 19% lower to $0.34, now conservatively covered by NII at 1.06x, and management permanently cut fees. Portfolio credit quality remains pressured: NAV has declined for eight straight quarters, non-accruals are 4.8%, and the watch list is 14.7%.
CCAP cut its dividend by 19% a few months ago. But I expect another dividend cut, as I see several signals of struggling NII. NII dropped nearly 22% year-over-year to $0.36 per share, leaving only a 6% margin of safety over the current base dividend and heightening payout risk.
Crescent Capital BDC, Inc. (CCAP) Q2 2026 Earnings Call Transcript
Crescent Capital BDC NASDAQ: CCAP reported second-quarter net investment income of $0.36 per share, exceeding its $0.34 per-share base dividend but declining from $0.38 per share in the prior quarter excluding a one-time incentive-fee waiver.
WP Carey (WPC) delivered a steady dividend raise, maintaining a 5.1% yield and demonstrating resilient income performance. Four BDCs—PFLT, CCAP, CGBD, OBDC—implemented double-digit dividend cuts, reflecting sector volatility and recent price declines near 52-week lows. Despite dividend reductions, all BDCs remain in the RIG portfolio, with recommendations to hold as dividend coverage stabilizes and recovery potential emerges.
LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, August 11, 2026 at 12:00 p.m. Eastern Time to discuss its second quarter ended June 30, 2026 financial results.
Crescent Capital BDC, Inc. faces ongoing headwinds, with a 19% dividend cut following rising non-accruals and declining investment income. Despite a steep 39% discount to NAV and a 12%+ yield, I remain cautious given persistent inflation and the potential for further downside. CCAP's Q1 saw net investment income drop to $0.38/share and non-accruals spike to 5.7% at cost, pressuring NAV and dividend sustainability.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CCAP and any ticker you trade — then tracks every position and per-strategy win rate.
